VEMIX Performance — Vanguard Emerging Markets Stock Index Fund, Institutional Shares
Data updated: 2026-09-28
VEMIX returned +9.18% year to date and +20.51% over one year to Jul 2026. Annualised returns are +14.19% over 3 years and +6.08% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $149, against $164 for the category, and to $121 over one year, against $134. Volatility over the past three years was 12.26% a year. In the 12 months to Jul 2026 the fund took in a net $12.8B, and assets reached $162.04B.
VEMIX Growth of $100
What $100 invested in Vanguard Emerging Markets Stock Index Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | VEMIX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $121 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $149 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $134 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $172 | $188 |
VEMIX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.18% |
| 1 year | +20.51% |
| 3 years (annualised) | +14.19% |
| 5 years (annualised) | +6.08% |
VEMIX Annual Returns
Calendar-year total returns of Vanguard Emerging Markets Stock Index Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.18% |
| 2025 | +24.79% |
| 2024 | +11.00% |
| 2023 | +9.23% |
| 2022 | −17.74% |
| 2021 | +0.92% |
| 2020 | +15.26% |
| 2019 (Aug–Dec) | +8.57% |
VEMIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.0% | +2.8% | −7.6% | +9.3% | +2.0% | −0.1% | −1.8% | — | — | — | — | — |
| 2025 | +0.5% | +0.2% | +1.4% | +0.2% | +3.8% | +5.2% | +1.1% | +3.0% | +5.7% | +1.4% | −1.2% | +1.2% |
| 2024 | −3.5% | +4.0% | +1.5% | +1.1% | +1.9% | +2.2% | +1.0% | +1.1% | +7.1% | −3.1% | −1.9% | −0.5% |
| 2023 | +7.7% | −6.2% | +2.6% | −0.6% | −2.4% | +4.3% | +5.9% | −5.7% | −2.1% | −3.4% | +6.8% | +3.3% |
| 2022 | +0.4% | −4.3% | −2.4% | −5.6% | +0.6% | −4.4% | −0.9% | +0.2% | −10.1% | −3.5% | +14.5% | −2.1% |
| 2021 | +2.9% | +1.7% | −1.0% | +1.9% | +2.0% | +1.2% | −6.3% | +2.7% | −3.3% | +1.1% | −3.2% | +1.8% |
| 2020 | −5.0% | −3.7% | −17.5% | +9.3% | +2.4% | +7.2% | +8.4% | +2.3% | −1.7% | +1.9% | +8.2% | +5.9% |
| 2019 | — | — | — | — | — | — | — | −3.8% | +1.4% | +3.9% | +0.2% | +7.0% |
VEMIX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.26%
- 3-year Sharpe ratio: 0.79 (vs 4.5% risk-free rate)
- Best month: +9.31% (Apr 2026)
- Worst month: −7.59% (Mar 2026)
VEMIX Fund Flows
Monthly money in and out of Vanguard Emerging Markets Stock Index Fund, from SEC Form N-PORT.
- 12-month net flow: $12.8B
- 12-month gross sales (incl. reinvestments): $20.6B
- Sales ÷ redemptions: 2.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $2.1B | $455.4M | $1.7B |
| Jun 2026 | $1.4B | $1.0B | $399.1M |
| May 2026 | $697.3M | $548.6M | $148.8M |
| Apr 2026 | $596.8M | $625.8M | −$29.0M |
| Mar 2026 | $834.9M | $675.1M | $159.8M |
| Feb 2026 | $2.6B | $523.0M | $2.1B |
| Jan 2026 | $2.9B | $946.6M | $2.0B |
| Dec 2025 | $3.1B | $610.8M | $2.5B |
| Nov 2025 | $2.5B | $750.5M | $1.8B |
| Oct 2025 | $1.7B | $673.8M | $979.7M |
| Sep 2025 | $1.6B | $546.6M | $1.0B |
| Aug 2025 | $596.3M | $432.1M | $164.1M |
VEMIX Assets Under Management
Net assets of Vanguard Emerging Markets Stock Index Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $162.04B |
| 2026-04-30 | $159.90B |
| 2026-01-31 | $151.77B |
| 2025-10-31 | $141.19B |
| 2025-07-31 | $126.55B |
| 2025-04-30 | $112.07B |
| 2025-01-31 | $109.54B |
| 2024-10-31 | $112.98B |
| 2024-07-31 | $107.54B |
| 2024-04-30 | $103.82B |
| 2024-01-31 | $97.95B |
| 2023-10-31 | $92.38B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.